Kodiak Selling General Administrative vs Research Development Analysis

KOD Stock

USD 10.00 0.15 1.48%

Kodiak Sciences financial indicator trend analysis is infinitely more than just investigating Kodiak Sciences recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Kodiak Sciences is a good investment. Please check the relationship between Kodiak Sciences Selling General Administrative and its Research Development accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Kodiak Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

For information on how to trade Kodiak Stock refer to our How to Trade Kodiak Stock guide.

Selling General Administrative vs Research Development

Selling General Administrative vs Research Development Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Kodiak Sciences Selling General Administrative account and Research Development. At this time, the significance of the direction appears to have almost identical trend.

The correlation between Kodiak Sciences' Selling General Administrative and Research Development is 0.92. Overlapping area represents the amount of variation of Selling General Administrative that can explain the historical movement of Research Development in the same time period over historical financial statements of Kodiak Sciences, assuming nothing else is changed. The correlation between historical values of Kodiak Sciences' Selling General Administrative and Research Development is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Selling General Administrative of Kodiak Sciences are associated (or correlated) with its Research Development. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Research Development has no effect on the direction of Selling General Administrative i.e., Kodiak Sciences' Selling General Administrative and Research Development go up and down completely randomly.

Correlation Coefficient

0.92

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Selling General Administrative

Research Development

Most indicators from Kodiak Sciences' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Kodiak Sciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Kodiak Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

For information on how to trade Kodiak Stock refer to our How to Trade Kodiak Stock guide.At present, Kodiak Sciences' Enterprise Value Over EBITDA is projected to slightly grow based on the last few years of reporting. The current year's Enterprise Value Multiple is expected to grow to 0.18, whereas Issuance Of Capital Stock is projected to grow to (263.3 K).

	2021	2022	2023	2024 (projected)
Depreciation And Amortization	8.7M	11.0M	18.3M	19.2M
Interest Income	298K	7.1M	16.7M	17.6M

Depreciation And Amortization Interest Income

Kodiak Sciences fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Long Term Debt	Cash And Short Term Investments	Common Stock Total Equity	Common Stock Shares Outstanding	Long Term Debt Total	Non Current Liabilities Total	Capital Surpluse	Capital Lease Obligations	Other Current Assets	Other Stockholder Equity	Total Liab
Total Assets		0.9	0.87	0.87	-0.16	0.86	0.98	0.71	-0.91	-0.62	0.84	0.94	0.78	0.7	0.86	0.69	0.99	0.84	0.86	0.69	0.82	0.85	0.9	0.95	0.85	0.85
Short Long Term Debt Total	0.9		0.87	0.95	0.16	0.96	0.88	0.88	-0.69	-0.83	0.96	0.76	0.93	0.75	0.96	0.7	0.83	0.8	0.92	0.7	0.96	0.93	1.0	0.92	0.96	0.98
Other Current Liab	0.87	0.87		0.97	-0.19	0.82	0.83	0.73	-0.73	-0.67	0.89	0.78	0.83	0.86	0.8	0.67	0.82	0.75	0.85	0.67	0.81	0.81	0.87	0.89	0.82	0.87
Total Current Liabilities	0.87	0.95	0.97		0.03	0.89	0.84	0.82	-0.66	-0.79	0.95	0.73	0.91	0.88	0.88	0.7	0.8	0.8	0.92	0.7	0.89	0.89	0.95	0.93	0.9	0.94
Total Stockholder Equity	-0.16	0.16	-0.19	0.03		0.24	-0.15	0.38	0.5	-0.52	0.08	-0.4	0.32	0.01	0.24	0.09	-0.25	0.06	0.15	0.09	0.13	0.26	0.16	0.01	0.26	0.11
Other Liab	0.86	0.96	0.82	0.89	0.24		0.85	0.96	-0.66	-0.91	0.93	0.74	0.97	0.64	1.0	0.7	0.79	0.78	0.9	0.7	0.91	0.98	0.96	0.87	1.0	0.92
Net Tangible Assets	0.98	0.88	0.83	0.84	-0.15	0.85		0.72	-0.91	-0.64	0.86	0.94	0.78	0.61	0.86	0.73	0.97	0.89	0.86	0.73	0.79	0.87	0.89	0.93	0.84	0.82
Property Plant And Equipment Net	0.71	0.88	0.73	0.82	0.38	0.96	0.72		-0.48	-0.98	0.88	0.58	0.98	0.54	0.96	0.68	0.63	0.73	0.84	0.68	0.81	0.96	0.88	0.75	0.97	0.83
Net Debt	-0.91	-0.69	-0.73	-0.66	0.5	-0.66	-0.91	-0.48		0.33	-0.67	-0.99	-0.53	-0.45	-0.67	-0.54	-0.94	-0.67	-0.64	-0.54	-0.65	-0.63	-0.7	-0.76	-0.63	-0.67
Retained Earnings	-0.62	-0.83	-0.67	-0.79	-0.52	-0.91	-0.64	-0.98	0.33		-0.84	-0.43	-0.96	-0.54	-0.9	-0.69	-0.52	-0.74	-0.81	-0.69	-0.74	-0.93	-0.83	-0.71	-0.92	-0.77
Accounts Payable	0.84	0.96	0.89	0.95	0.08	0.93	0.86	0.88	-0.67	-0.84		0.74	0.92	0.69	0.92	0.72	0.76	0.81	0.93	0.72	0.91	0.91	0.95	0.85	0.93	0.94
Cash	0.94	0.76	0.78	0.73	-0.4	0.74	0.94	0.58	-0.99	-0.43	0.74		0.62	0.5	0.75	0.6	0.97	0.72	0.71	0.6	0.72	0.72	0.77	0.82	0.72	0.74
Non Current Assets Total	0.78	0.93	0.83	0.91	0.32	0.97	0.78	0.98	-0.53	-0.96	0.92	0.62		0.7	0.97	0.7	0.7	0.78	0.9	0.7	0.86	0.97	0.93	0.85	0.98	0.89
Non Currrent Assets Other	0.7	0.75	0.86	0.88	0.01	0.64	0.61	0.54	-0.45	-0.54	0.69	0.5	0.7		0.62	0.46	0.63	0.59	0.74	0.46	0.71	0.63	0.76	0.83	0.66	0.77
Other Assets	0.86	0.96	0.8	0.88	0.24	1.0	0.86	0.96	-0.67	-0.9	0.92	0.75	0.97	0.62		0.7	0.8	0.78	0.89	0.7	0.91	0.98	0.96	0.87	1.0	0.92
Long Term Debt	0.69	0.7	0.67	0.7	0.09	0.7	0.73	0.68	-0.54	-0.69	0.72	0.6	0.7	0.46	0.7		0.67	0.86	0.62	1.0	0.5	0.78	0.67	0.73	0.71	0.56
Cash And Short Term Investments	0.99	0.83	0.82	0.8	-0.25	0.79	0.97	0.63	-0.94	-0.52	0.76	0.97	0.7	0.63	0.8	0.67		0.8	0.79	0.67	0.75	0.79	0.83	0.91	0.78	0.78
Common Stock Total Equity	0.84	0.8	0.75	0.8	0.06	0.78	0.89	0.73	-0.67	-0.74	0.81	0.72	0.78	0.59	0.78	0.86	0.8		0.78	0.86	0.61	0.87	0.81	0.88	0.78	0.67
Common Stock Shares Outstanding	0.86	0.92	0.85	0.92	0.15	0.9	0.86	0.84	-0.64	-0.81	0.93	0.71	0.9	0.74	0.89	0.62	0.79	0.78		0.62	0.89	0.9	0.93	0.86	0.91	0.92
Long Term Debt Total	0.69	0.7	0.67	0.7	0.09	0.7	0.73	0.68	-0.54	-0.69	0.72	0.6	0.7	0.46	0.7	1.0	0.67	0.86	0.62		0.5	0.78	0.67	0.73	0.71	0.56
Non Current Liabilities Total	0.82	0.96	0.81	0.89	0.13	0.91	0.79	0.81	-0.65	-0.74	0.91	0.72	0.86	0.71	0.91	0.5	0.75	0.61	0.89	0.5		0.82	0.95	0.82	0.91	0.99
Capital Surpluse	0.85	0.93	0.81	0.89	0.26	0.98	0.87	0.96	-0.63	-0.93	0.91	0.72	0.97	0.63	0.98	0.78	0.79	0.87	0.9	0.78	0.82		0.93	0.88	0.98	0.86
Capital Lease Obligations	0.9	1.0	0.87	0.95	0.16	0.96	0.89	0.88	-0.7	-0.83	0.95	0.77	0.93	0.76	0.96	0.67	0.83	0.81	0.93	0.67	0.95	0.93		0.93	0.96	0.97
Other Current Assets	0.95	0.92	0.89	0.93	0.01	0.87	0.93	0.75	-0.76	-0.71	0.85	0.82	0.85	0.83	0.87	0.73	0.91	0.88	0.86	0.73	0.82	0.88	0.93		0.87	0.86
Other Stockholder Equity	0.85	0.96	0.82	0.9	0.26	1.0	0.84	0.97	-0.63	-0.92	0.93	0.72	0.98	0.66	1.0	0.71	0.78	0.78	0.91	0.71	0.91	0.98	0.96	0.87		0.93
Total Liab	0.85	0.98	0.87	0.94	0.11	0.92	0.82	0.83	-0.67	-0.77	0.94	0.74	0.89	0.77	0.92	0.56	0.78	0.67	0.92	0.56	0.99	0.86	0.97	0.86	0.93

Click cells to compare fundamentals

Kodiak Sciences Account Relationship Matchups

Kodiak Sciences fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	358.9M	1.1B	904.2M	666.6M	479.4M	492.8M
Other Current Liab	8.7M	18.0M	44.4M	23.5M	18.4M	17.0M
Total Current Liabilities	11.7M	31.4M	64.7M	52.5M	41.7M	30.0M
Total Stockholder Equity	(158.1M)	(291.2M)	(558.2M)	436.2M	265.8M	279.1M
Other Liab	530K	295K	100.1M	100.2M	115.2M	120.9M
Net Tangible Assets	345.4M	860.8M	663.3M	436.2M	501.6M	358.7M
Property Plant And Equipment Net	2.8M	78.8M	108.1M	115.8M	175.0M	183.8M
Net Debt	(209.9M)	(867.0M)	(651.5M)	(102.7M)	(203.9M)	(214.1M)
Retained Earnings	(158.1M)	(291.2M)	(558.2M)	(892.0M)	(1.2B)	(1.1B)
Accounts Payable	2.6M	8.6M	12.4M	9.1M	13.6M	7.1M
Cash	211.8M	944.4M	731.5M	190.4M	285.5M	338.7M
Non Current Assets Total	19.6M	95.3M	169.4M	180.6M	190.1M	199.6M
Non Currrent Assets Other	5.2M	10.2M	55.0M	58.5M	8.7M	8.3M
Other Assets	0.0	68.7M	61.3M	64.9M	74.6M	78.3M
Cash And Short Term Investments	348.2M	969.0M	731.5M	478.9M	285.5M	400.5M
Common Stock Shares Outstanding	37.9M	45.7M	51.8M	52.2M	52.4M	42.4M
Liabilities And Stockholders Equity	(144.6M)	(84.6M)	(317.3M)	666.6M	479.4M	503.3M
Non Current Liabilities Total	1.8M	175.2M	176.2M	178.0M	171.9M	112.3M
Capital Surpluse	503.5M	1.2B	1.2B	1.3B	1.5B	1.6B
Other Current Assets	2.7M	6.1M	6.6M	7.1M	3.8M	4.0M
Other Stockholder Equity	(15K)	1.2B	1.2B	1.3B	1.4B	1.5B
Total Liab	13.5M	206.6M	240.9M	230.5M	213.6M	142.4M
Property Plant And Equipment Gross	2.8M	78.8M	111.0M	122.5M	197.6M	207.5M
Total Current Assets	339.2M	972.0M	734.8M	486.0M	289.3M	402.0M
Accumulated Other Comprehensive Income	10K	53K	0.0	(1.3M)	(1.5M)	(1.6M)
Non Current Liabilities Other	295K	175.2M	176.2M	178.0M	100M	86.8M
Property Plant Equipment	2.8M	5.1M	108.1M	56.4M	64.8M	68.1M
Net Invested Capital	345.4M	860.8M	663.3M	436.2M	265.8M	408.5M
Net Working Capital	327.5M	940.6M	670.1M	433.5M	247.6M	423.9M
Retained Earnings Total Equity	(158.1M)	(291.2M)	(558.2M)	(892.0M)	(802.8M)	(762.7M)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

C	Citigroup
GM	General Motors
F	Ford Motor

When determining whether Kodiak Sciences is a strong investment it is important to analyze Kodiak Sciences' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Kodiak Sciences' future performance. For an informed investment choice regarding Kodiak Stock, refer to the following important reports:

How To Invest In Kodiak

Details

Is Kodiak Stock a good investment?

Details

What is Kodiak Sciences' Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Kodiak Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

For information on how to trade Kodiak Stock refer to our How to Trade Kodiak Stock guide.

You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Kodiak Sciences. If investors know Kodiak will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Kodiak Sciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(3.64)

Return On Assets

(0.27)

Return On Equity

(0.71)

The market value of Kodiak Sciences is measured differently than its book value, which is the value of Kodiak that is recorded on the company's balance sheet. Investors also form their own opinion of Kodiak Sciences' value that differs from its market value or its book value, called intrinsic value, which is Kodiak Sciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Kodiak Sciences' market value can be influenced by many factors that don't directly affect Kodiak Sciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Kodiak Sciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Kodiak Sciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Kodiak Sciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Kodiak Selling General Administrative vs Research Development Analysis

Selling General Administrative vs Research Development

Selling General Administrative vs Research Development Correlation Analysis

Correlation Coefficient

Selling General Administrative

Research Development

Kodiak Sciences fundamental ratios Correlations

Kodiak Sciences Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Kodiak Sciences fundamental ratios Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Capital Lease Obligations	+ 1.0	Short Long Term Debt Total
Other Assets	+ 1.0	Other Liab
Other Stockholder Equity	+ 1.0	Other Liab
Other Stockholder Equity	+ 1.0	Other Assets
Long Term Debt Total	+ 1.0	Long Term Debt
Cash And Short Term Investments	+ 0.99	Total Assets

Cash	- 0.99	Net Debt
Retained Earnings	- 0.98	Property Plant And Equipment Net
Non Current Assets Total	- 0.96	Retained Earnings
Cash And Short Term Investments	- 0.94	Net Debt
Capital Surpluse	- 0.93	Retained Earnings
Other Stockholder Equity	- 0.92	Retained Earnings